PRESS RELEASE
5 August 2025

Sheppard Mullin Represented ArchiMed In Acquisition Of Arkstone Medical Group

SM
Sheppard Mullin Richter & Hampton

Contributor

Sheppard Mullin is a full service Global 100 firm with over 1,000 attorneys in 16 offices located in the United States, Europe and Asia. Since 1927, companies have turned to Sheppard Mullin to handle corporate and technology matters, high stakes litigation and complex financial transactions. In the US, the firm’s clients include more than half of the Fortune 100.
The firm represented European-based private equity fund ArchiMed in its acquisition of Arkstone Medical Group, a biotechnology company providing clinical decision support powered by ML and AI...
United States

The firm represented European-based private equity fund ArchiMed in its acquisition of Arkstone Medical Group, a biotechnology company providing clinical decision support powered by ML and AI, helping healthcare providers optimize antimicrobial use. The transaction will allow Arkstone expand its global footprint, deepen its R&D capabilities and bring its precision-guided technology to more clinicians around the world. Financial terms were not disclosed.

The Sheppard Mullin deal team that represented ArchiMed was led by partners Valerie Demont and Matt McCalip and associate Ines Briand. Invaluable assistance was provided by partners Niya Tang, Dmitry Chelnitsky, Daniel Yannuzzi, Sean Kirby, Reid Whitten and Carolyn Metnick, special counsel Malika Levarlet, and associates Theo Mayer, Michael Weisshar, Iman Naieem and Michael Sutton.

Read the press release here.

Contributor

Sheppard Mullin is a full service Global 100 firm with over 1,000 attorneys in 16 offices located in the United States, Europe and Asia. Since 1927, companies have turned to Sheppard Mullin to handle corporate and technology matters, high stakes litigation and complex financial transactions. In the US, the firm’s clients include more than half of the Fortune 100.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More